FY4/21
IR PRESENTATION

June 2021

Results Overview© 2020 AIN HOLDINGS INC. All Rights Reserved.

1

Consolidated P/L
Net sales increased 1.6% YoY and decreased 0.9% against the plan due to the contribution of store
opened in previous year, despite the impact of the COVID-19. Ordinary income declined 24.8% YoY due
to lower gross profit margins and up 26.5% against the plan.

(¥ million)

FY4/20results

FY4/21
plan

FY4/21
results

YoYchangeYoYchange(%)

Vs plan(%)

Net sales

292,615300,000

297,305+4,690

+1.6

(0.9)

Gross profit

46,86145,40046,155

(706)

(1.5)

+1.7

SG&A expenses

30,79336,20035,222+4,429

+14.4

(2.7)

Operating income

16,0689,200

10,932(5,136)(32.0)+18.8

Ordinary income

16,822

10,00012,649(4,173)(24.8)+26.5

Profit attributable toowners of parent

9,179

5,000

6,697

(2,482)(27.0)+33.9% of net sales

3.1

1.7

2.3

Earnings per
share(¥)）

259.11141.13189.04(70.07)(27.0)+33.9% of net sales% of net sales% of net sales% of net sales

16.0
10.5
5.5
5.7

15.1
12.1
3.1
3.3

15.5
11.8
3.7
4.3

Figures in the table are rounded down
FY4/21 plan is revised in December 3, 2020
© 2020 AIN HOLDINGS INC. All Rights Reserved.

2

Dispensing Pharmacy Business (Consolidated)
Net sales decreased 0.2% YoY and 0.6% against the plan due to the reduction of prescription volume
caused by impact of the COVID-19 outbreak. Segment income up 0.5% YoY and 15.1% against the plandue to raising efficiency of store operation.
YoYchange(¥ million)

FY4/20results

FY4/21
plan

FY4/21
results

Net sales

263,750

263,095

(655)

(0.2)

(0.6)

Gross profit

34,960264,800
32,40033,160(1,800)

(5.1)

+2.3

14,664

14,90013,998

(666)

(4.5)

(6.1)

20,29517,50019,162(1,133)

(5.6)

+9.5

20,85018,20020,947

+97

+0.5

+15.1

1,088

1,079

1,065

(23)

(2.1)

(1.3)

% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Segment income% of net sales

Number ofpharmacies

13.3
5.6
7.7
7.9

12.2
5.6
6.6
6.9

12.6
5.3
7.3

YoY
change(%)

Vs plan(%)

8.0

Figures in the table are rounded down
FY4/21 plan is revised in December 3, 2020

© 2020 AIN HOLDINGS INC. All Rights Reserved.

3

Cosmetic and Drug Store Business (Consolidated)
Net sales declined 21.4% YoY and 2.9% against the plan due to temporarily closed or shorted
opening hours at many stores. Segment loss was ¥1,999 million due to net sales declined.

(¥ million)

FY4/20results

FY4/21
plan

FY4/21
results

YoYchangeYoYchange(%)

Net sales

24,701

19,419(5,282)(21.4)(2.9)

Gross profit

9,753

20,000
7,330

7,216

(2,537)(26.0)

(1.6)

9,596

9,680

9,358

(238)

(2.5)

(3.3)

157

(2,350)(2,141)(2,298)--262(2,200)(1,999)(2,261)

-

-

63

69

69

+6

+9.5

+0.0

% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Segment income% of net sales

Number of stores

39.5
38.8
0.6
1.1

36.7
48.4

-

37.2
48.2

-

Vs plan(%)-

Figures in the table are rounded down
FY4/21 plan is revised in December 3, 2020

© 2020 AIN HOLDINGS INC. All Rights Reserved.

4

Consolidated B/S
Net cash became ¥43,171 million and shareholders’ equity ratio became 56.8%. We are
maintaining a sound financial structure even during the COVID-19 outbreak.
(¥ million)(¥ million)

End-FY4/21

End-FY4/20
AssetsCurrent assets
Cash on hand andin banks

Fixed assets

AssetsLiabilities

87,802 Current liabilities
46,321

105,632

74,700

Short-term debt
Lease obligations

3,642
193

Long-term
liabilities

7,747

107,264

Short-term debt
Lease obligations

3,670
94

Long-term
liabilities

13,664Long-term debt
Lease obligations

8,297
37

111,003

Deferred
assets-Total net assets

115,837

193,451

Total assets

203,662

Total liabilities
and net assets

203,662

39,899Net cashLong-term debt
Lease obligations

2,432
154

Deferred
assets15

Total net assets

193,451

Total liabilities
and net assets

Shareholders’ equity
ratio(%)

Fixed assets

55,271

74,16039,05742,123

Net cashCash on hand andin banks

96,398 Current liabilities

Goodwill

Goodwill

Total assets

Current assets

Liabilities

57.3

Shareholders’ equity
ratio(%)

43,171
56.8

Figures in the table are rounded down
Net cash = Cash on hand and in banks – Interest-bearing debt (Long-and short-term debt + Lease obligations)© 2020 AIN HOLDINGS INC. All Rights Reserved.

5

Assets
The balance of total assets increased ¥10,211 million from the end of the previous fiscal year
due to increase of cash on hand and in banks.
(¥ million)
Cash on hand and in banks
Notes and accounts receivable
Inventories
Total current assets
Buildings and structures,net
Land
Lease assets
Total property,plant and equipment
Goodwill
Lease assets
Total intangible fixed assets
Investments in securities
Deferred tax assets
Deposits and guarantees
Total investments and other assets
Total fixed assets
Total deferred assets
Total assets

Figures in the table are rounded down

End-FY4/19

48,091
12,771
12,89885,446
16,352
10,394571
30,18645,2497
47,577
1,795
4,284
15,13325,751
103,51559
189,021End-FY4/20

46,321
13,653
15,32287,802
16,60910,960272
30,874
42,123
5
44,916
2,295
4,211
19,14429,841
105,632
15
193,451

End-FY4/21

55,271
13,475
14,28596,398
16,270
10,390100
30,22939,057
1
42,666
2,697
4,415
20,31934,368107,264
203,662

Change+8,950(178)(1,037)+8,596
(339)
(570)
(172)
(645)
(3,066)(4)(2,250)+402+204+1,175+4,527+1,632(15)+10,211

Change:End-FY4/21 compared with End-FY4/20

Capital expenditures (Property, plant and equipment and intangible fixed assets + Deposits and guarantees) totaled ¥8,122 million© 2020 AIN HOLDINGS INC. All Rights Reserved.

6

Liabilities and Net Assets
The balance of liabilities increased ¥5,378 million from the end of the previous fiscal year due
to increase of long-term debt for investment purpose.
(¥ million)

End-FY4/19

End-FY4/20

End-FY4/21

ChangeShort-term debt

44,794
5,571

47,1873,642

46,758
3,670

(429)
+28

Lease obligations

318

193

94

(99)

73,74474,70074,160(540)

Long-term debt

5,985

2,432

8,297

+5,865

Lease obligations

401

154

37

(117)

Total long-term liabilities

11,355

7,747

13,664+5,917

Total liabilities

85,09982,447

87,825+5,378

Common stock

Total shareholders’ equity

21,89420,50061,526
103,920

21,89420,50068,758111,151

21,89420,50073,506
115,899+4,748+4,748

Total net assets

103,922

111,003

115,837+4,834

Total liabilities and net assets

189,021

193,451

203,662+10,211

Accounts payable

Total current liabilities

Capital surplus
Retained earnings

Figures in the table are rounded down

© 2020 AIN HOLDINGS INC. All Rights Reserved.

Change:End-FY4/21 compared with End-FY4/20

7

Consolidated C/F
Operating activities was ¥14,928 million due to active new store opening especially focus on largescale store. Cash and cash equivalents at end of the year increased ¥9,078 due to increase of longterm debt.
(¥ million)

FY4/20FY4/21

Change17,747

14,928(2,819)15,93011,767(4,163)

Depreciation and amortization

4,087

4,243

+156

Amortization of goodwill

4,357

4,436

+79

Increase (decrease) in accounts receivable

▲429

138

+567

▲1,9391,172+3,111

Increase (decrease) in other accounts receivable

▲530

▲221

+309

(Increase) decrease in accounts payable

1,793

▲844

(2,637)▲11,474▲9,493+1,981▲6,378▲5,742+636▲1,442▲997+445

Net cash provided by financing activities▲7,837

3,643+11,480

Net increase in cash and cash equivalents▲1,564

9,078+10,642

Cash and cash equivalents at end of the year

45,93155,009+9,078Net cash provided by operating activities
Profit before income taxes

Increase (decrease) in inventories

Net cash used in investing activities
Payments for purchases of property, plantand equipment and intangible fixed assets
Purchase of subsidiaries’ shares resulting
in obtaining controls

Figures in the table are rounded down
© 2020 AIN HOLDINGS INC. All Rights Reserved.

8

Business Value Analysis
FY4/19

Shareholders’ equity ratio (%)
Market value equity ratio (%)
PER (times)
EPS (¥)PBR (times)
BPS (¥)ROA (%)ROE (%)EBITDA (¥ million)
EV/EBITDA (times)
Net D/E ratio (times)
Net cash (¥ million)
Shareholders’ value (¥ million)
Market capitalization (¥ million)

54.9
165.7
34.68
254.873.01
2,931.48
4.8
9.0
24,15411.52▲0.34
35,814314,139
313,178

FY4/20

57.3
110.4
23.27
259.11
1.92
3,130.77
4.8
8.5
24,5137.11▲0.36
39,899214,258
213,627

FY4/21

56.8
105.6
32.11
189.04
1.86
3,267.49
3.4
5.9
19,6128.80▲0.37
43,171
215,710215,043

Change

(0.5)
(4.8)
+8.84
(70.07)(0.06)+136.72(1.4)(2.6)(4,901)+1.69(0.01)+3,272+1,452+1,416

Figures in the table are rounded down
Change：FY4/21 compared with FY4/20
Net D/E ratio = (Interest-bearing debt – Cash on hand and in banks) / Shareholders’ equity
Shareholders’ value = EV – Net interest-bearing debt
Market capitalization：Treasury stock is excepted
Share prices used to calculate market capitalization:
End-FY4/19 ¥8,840 (End-Apr,2019), End-FY4/20 ¥6,030 (End-Apr,2020), End-FY4/21 ¥6,070 (End-Apr,2021).
Net cash = Cash on hand and in banks – Interest-bearing debt (Long-and short-term debt + Lease obligations )© 2020 AIN HOLDINGS INC. All Rights Reserved.

9

FY4/22 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2022 of ¥315,000 million,
increase 6.0% YoY and ordinary income of ¥15,500 million, increase 22.5% YoY.
YoYchangeFY4/20results

FY4/21
results

FY4/22plan

Net sales

292,615

297,305

315,000 +17,695+6.0

Gross profit

46,861

46,15551,600+5,445+11.8

30,79335,22236,600+1,378+3.9

16,068

10,932

15,000+4,068+37.2

16,822

12,64915,500+2,851

+22.5

9,179

6,697

8,300

+1,603+23.9% of net sales

3.1

2.3

2.6

Earnings per
share(¥)

259.11189.04234.28+45.24

+23.9

55.00

55.00

55.00

+0.00

+0.0

（¥ million）% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Ordinary income% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

16.0
10.5
5.5
5.7

15.5
11.8
3.7
4.3

16.4
11.6
4.8

YoY
change(%)

4.9

Figures in the table are rounded down
© 2020 AIN HOLDINGS INC. All Rights Reserved.

10

Review© 2020 AIN HOLDINGS INC. All Rights Reserved.

11

Daily new COVID-19 cases across Japan
As of June 10, the number of domestic cases of the COVID-19 infection and deaths was
762,459 and 13,908, respectively.
Second declaration of
the state of emergency（people）
12,000Third declaration of
the state of emergency
Apr.25－in Tokyo, Kyoto,
Osaka and Hyogo

Jan.8－Mar.21
in Saitama, Chiba,
Tokyo and Kanagawa

No. of positive cases
10,000

May.12－in Hokkaido,
Okayama,
Hiroshimaand（－Feb.7
May 12
Okinawa
Tochigi ） 7,057

Jan.13－Feb.28
in Gifu, Aichi, Kyoto, Osaka,
Hyogo and Fukuoka

8,000

Apr.7－May.25
Declaration of
the state of emergency
nationwide

6,000

Jan.8
7,844

Feb.28－Mar.19
Declaration of
the state of emergency
in Hokkaido

4,000

Aug.7
1,595

Apr.10708

June 10
2,046
5

（m/y）

5/26

4/24

4

4/8

3/23

3

3/7

2/19

2

2/3

1/18

1/21

1/2

12/17

12

12/1

11

11/15

10/30

10

10/14

9/28

9

9/12

8

8/11

7/26

7

7/10

6/24

6

6/8

5/23

5

5/7

4/21

4

4/5

3

3/20

3/4

2

2/17

2/1

20/1/16

1/20

8/27

0

5/10

2,000

the Ministry of Health, Labour and Welfare's Open Data on the COVID-19© 2020 AIN HOLDINGS INC. All Rights Reserved.

12

Review (YoY)
Ordinary income decreased ¥4.2 billion because declined net sales couldn’t absorb investments
costs for system etc. and labor costs for new employees.

Net sales

Ordinary income+¥4.6 billion¥292.6 billion¥(4.2) billion¥297.3 billion¥16.8 billion

Dispensing
Pharmacy¥263.7 billion

Dispensing
Pharmacy

Others ¥4.2 billion

FY4/20results

FY4/21
results¥24.7 billion¥(0.7)billion¥263.0 billion
Cosmetic andDrug Store
¥19.4 billion
Others¥14.9 billion

Cosmetic andDrug Store

Dispensing
Pharmacy

Cosmetic andDrug store¥12.6 billion
Dispensing
Pharmacy¥20.8 billion¥(5.2)billion
Retail shop
Others+¥10.5 billion

Cosmetic andDrug Store¥0.2 billion

Others ¥(0.3) billion

Administrative
expense¥(3.9) billion

FY4/20results© 2020 AIN HOLDINGS INC. All Rights Reserved.

Dispensing
Pharmacy¥20.9 billion
Cosmetic andDrug Store¥(2.0) billion

Others ¥(0.7) billion

Administrative
expense¥(5.6) billion

FY4/21
results

Declined sales
Others¥(2.5)billion

Investments
for system
Others¥(1.7)billion

13

Review (Vs plan)
Although net sales fell below the plan, ordinary income increased ¥2.6 billion against the plandue to cost reduction, etc.

Net sales¥300.0 billion

Dispensing
Pharmacy¥264.8 billion

Cosmetic andDrug Store¥20.0 billion
Others¥15.2 billion

FY4/21plan

Ordinary income¥(2.7) billion¥297.3 billion

Dispensing
Pharmacy¥12.6 billion
Dispensing
Pharmacy

Others¥14.9 billion

FY4/21
results¥10.0 billion¥(1.8)billion¥263.0 billion
Cosmetic andDrug Store
¥19.4 billion

Cosmetic andDrug store¥(0.6)billion
Retail shop
Others¥(0.3) billion

Dispensing
Pharmacy

Dispensing
Pharmacy
Cost reduction¥20.9 billion¥18.2 billion
Cosmetic andDrug Store¥(2.2) billion

Others ¥(0.5) billion

Administrative
expense¥(5.5) billion© 2020 AIN HOLDINGS INC. All Rights Reserved.

+¥2.6 billion

FY4/21plan+¥2.7 billion

Cosmetic andDrug Store¥(2.0) billion

Others ¥(0.7) billion

Administrative
expense¥(5.6) billion

FY4/21
results

Administrative
expense¥(0.1)billion

14

Strategy© 2020 AIN HOLDINGS INC. All Rights Reserved.

15

Strategy
Expansion of Top-line■Dispensing Pharmacy

Planning to open 80 pharmacies （Organic 40, M&A 40 ）■Cosmetic and Drug Store

Planning to open 15 stores

Proper staffing■Planning to hire 600 newly graduated pharmacists（hired 613 new pharmacists in FY4/21）■Assign personnel properly and strengthening recruitment of full-time employees
Newly assign 100 employees dedicated to the management of dispensing pharmacies

Reinforcing the Group’s business base■Promoting Sustainable Management■Securing specialized human resources with expertise in IT and logistics■Raising the operating efficiency by introducing RPA robots■Improving the customer services by enhancing official app and EC website■Logistic reform in anticipation of expansion of Top-line© 2020 AIN HOLDINGS INC. All Rights Reserved.

16

Top-line
The group opened 40 stores including M&A, and closed 57 stores during the FY4/21. We plan
to open 95 and close 7 stores, resulting in a total of 1,222 stores at the end of the FY4/22.
■ PlanFY4/22

FY4/21Results

Plan

Dispensing Pharmacy

38

29

80

Organic

16

15

40

M&A

22

14

40

Cosmetic and drug store

11

11

15

Total

49

40

95

Dispensing Pharmacy

47

52

Cosmetic and drug store

5

5

5
2

Total

52

57

7

1,079

1,065

1,140

Cosmetic and drug store

69

69

Total no. of stores

1,148

1,134

■ Transition of dispensing pharmacies
FY4/13 FY4/14

FY4/15

FY4/16

FY4/17

FY4/18

FY4/19FY4/20FY4/21

ClosureOpening

Plan

Dispensing Pharmacy

Organic
M&A

EV/EBITDA ratio

ClosedSold

No. of total stores

Hokkaido
122
Koshinetsu
106
Chugoku,
Shikoku
91

82

1,222

Tohoku170

Hokuriku
25

Kyusyu, Okinawa
45

Kanto
363

Kinki
128

Tokai
84
End-FY4/21

38

36

40

32

27

25

23

14

15

38
5.09

26
3.94

119
4.77

110
5.37

182
5.50

11
3.96

134
4.88

6
3.71

14
3.74

10
560

6
1
616

21
1
754

15
1
881

24
2
1,066

73
32
1,029

54
30
1,132

64
42
1,088

52
34
1,065

EV/EBITDA ratio=EV(Purchase price)/EBITDA(Operating income + Depreciation and amortization)© 2020 AIN HOLDINGS INC. All Rights Reserved.

17

Recruiting of Pharmacists
In April 2021, new 613 pharmacists has joined our group. We aim to hire roughly the same
number in fiscal 2022 to prepare for expansion of business scale by accelerating store openings.
■ The transition of No. of national examination passers and new qualified pharmacists in AIN Group2013（People）

No. of newly qualified
pharmacists hired in
AIN Group
No. of pharmacists’national examination
passers (pass rate)
Rate of newly qualified
pharmacists hired in
AIN Group

2014

2015

2016

2017

2018

2019

2020

2022
(Plan)

2021

251

251

229

375

307

279

257

560

613

600

8,929

7,312

9,044

11,488

9,479

9,584

10,194

9,958

9,634

-

2.5%

3.3%

3.2%

6.4%

-

（79.1%） （60.8%） （63.2%） （76.9%） （71.6%） （70.6%） （70.9%） （69.6％） （68.7％）

3.4%

2.8%

（7.0%）（8.0%）（8.0%） （11.7%） （10.0%）

2.9%（8.0％）

2.5%（5.8%)

（

5.6%
-

）

（

-

）

Estimates : based on the result in AIN Group, and data from the Ministry of Health, Labor and Welfare, Council on Pharmaceutical Education.

（People）

1,200

General staff

Pharmacists

No. of newly-hired employees

1,000
800
600
400
200
0

375
251

251

53

28

2013

2014

© 2020 AIN HOLDINGS INC. All Rights Reserved.

229

307

279

93

173

174

152

2015

2016

2017

2018

560

613

392

405

350

2020

2021

2022 （year）

600

257
277

2019

（Plan）

18

Pharmacies as social infrastructure“Pharmacy’s vision for patients“

Certified pharmacies

Function of advanced
pharmaceutical management

Function of pharmacies cooperating withspecialized medical institutions

Healthcare support pharmacies■Securing pharmacists' expertise for advanced
pharmaceutical management■Information sharing with specialized medical
institutions

Pharmacies that can handle special dispensing that
requires a higher level of pharmaceuticalmanagement, working closely with other healthcare
provider facilities for patients who require specialized
pharmaceutical management such as those withcancer.

Function of primary carepharmacists and pharmacies

Function of community pharmacies■Integrated and continuous monitoring andguidance of patients' medication information■Provide patient medication information to doctors■Support patients in the night and holidays■Home based health care
■Information sharing with medical institutions /Suggest changes in prescriptions for the better

Pharmacies that work for integrated and continuous
information coordination of medication information
with other healthcare provider facilities, not only
during outpatient visits, but also when responding tohome based healthcare and when admitting anddischarging patients.

■Health consultations /Encourage patient for medical examination■pharmacist who have completed training in
health support on duty at all times■Conducting drug counseling sessions for residents■Supply of pharmaceuticals requiring guidance,
hygiene materials, nursing care products, etc.

In addition to the basic functions of primary carepharmacists and pharmacies, pharmacies equippedwith health support functions that actively
support the proactive maintenance andpromotion of health by citizens.

© 2020 AIN HOLDINGS INC. All Rights Reserved.

19

FY4/22 Plan (Consolidated) Basis of the plan
The group expects to recover gradually from impact of the COVID-19 in FY4/22. We willcontinue store opening including M&A, securing dispensing fee, effective store operation
and reinforcing business base.
Net sales

Ordinary income+¥17.7 billion¥297.3 billion

Dispensing
Pharmacy¥263.0 billion¥315.0 billion¥15.5 billion
Dispensing
Pharmacy

Dispensing
Pharmacy

Dispensing
Pharmacy¥276.3 billion

Cosmetic and
Cosmetic andDrug Store
Drug Store
¥19.4 billion¥25.0 billion
Others ¥14.9 billion Others ¥13.7 billion Retail shop
OthersFY4/21
FY4/22¥(1.2)billionplan© 2020 AIN HOLDINGS INC. All Rights Reserved.

¥12.6 billion+¥13.3 billion

Cosmetic andDrug store+¥5.6 billion

results+¥2.9 billion

Dispensing
Pharmacy¥22.7 billion

Net sales
Others+¥3.9 billion¥20.9 billion
Cosmetic andDrug Store¥(2.0) billion

Others ¥(0.7) billion

Administrative
expense¥(5.6) billion

FY4/21
results

Others ¥0.1 billion

Administrative
expense¥(6.6) billion

FY4/22plan

Administrative
expense¥(1.0)billion
Cosmetic andDrug Store¥(0.7) billion
20

FY4/22 Plan (Dispensing Pharmacy Business)
The group forecasts net sales for the fiscal year ending April 30, 2022 increase 5.0% andSegment income increase 8.4% YoY by opening 80 new stores including M&A and closing
5 stores.
YoYchange(¥ million)

FY4/20results

FY4/21
results

FY4/22plan

Net sales

263,750

263,095

276,300 +13,205+5.0

Gross profit

34,96033,16036,900+3,740+11.3

14,664

13,99814,600+602+4.3

20,295

19,162

22,300+3,138+16.4

20,85020,94722,700+1,753

+8.4

1,088

1,065

1,140

+75

+7.0

% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Segment income% of net sales

Number ofpharmacies

13.3
5.6
7.7
7.9

12.6
5.3
7.3
8.0

13.4
5.3
8.1
8.2

YoY
change(%)

Figures in the table are rounded down
Segment income is adjusted to ordinary income shown on the consolidated statements of income© 2020 AIN HOLDINGS INC. All Rights Reserved.

21

ainz & tulpe ①
ainz & tulpe
new store opening in FY4/21

11

stores

Sapporo Kokusai bldg. (Dec. 2020)
Daimaru Kyoto（Jun. 2020）

Tekute Nagamachi（ Mar. 2021）
Hikarigaoka IMA(Dec. 2020)
Hibiya chanter(Jul. 2020)

Daimaru Umeda（Jun. 2020）

Tokyu plaza totsuka（Sep. 2020）

AMU PLAZA Kumamoto（Apr. 2021）

Sanste okayama（Sep. 2020）© 2020 AIN HOLDINGS INC. All Rights Reserved.

Dai Nagoya bldg.
（Apr. 2021）

LaLaport TACHIKAWATACHIHI（Mar. 2021）
22

② New store review
Normally, ainz & tulpe grows in the second and third year of store openings with increase ofcustomer recognition, but now stores do not achieve its original profitability affected byspread of the COVID-19 infection.
■ Average monthly net sales（Before impact of the COVID-19)
Opened in FY4/17 (5 stores)

Opened in FY4/16 (4 stores)100%

1st year122%

2nd year

145%

・SHINJUKUHIGASHIGUCHI・Le troi・Marui city Yokohama
・NEW CHITOSE
AIRPORT

3rd year

192%
148%

1st year

2nd year・Kita-Senju Marui・Colette Mare(1F)・MARRONNIER GATE
GINZA・Keio Department
Store Shinjuku
・JOINUS YOKOHAMA

3rd year■ Average monthly net sales（After impact of the COVID-19)
Opened in FY4/19 (6 stores)

Opened in FY4/18 (4 stores)

1st year・Odakyu Machida・Marui Kichijoji
・Grand EmioTOKOROZAWA(1F)・Grand EmioTOKOROZAWA(2F)

113%

117%

2nd year

3rd year（FY4/20）© 2020 AIN HOLDINGS INC. All Rights Reserved.

113%

1st year

88%

・OLINAS KINSHICHO・SOKA VARIE・SHIBUYA KOEN-DORI
・Fuchu Foris
・Abeno Hoop
・UMEDA HEP FIVE

2nd year
3rd year（FY4/20） （FY4/21）
23

FY4/22 Plan (Cosmetic and Drug Store Business)
The group forecasts net sales for the fiscal year ending April 30, 2022 increase 28.7% YoY
and segment income increase ¥1.3 billion by opening 15 new stores and closing 2 stores.

(¥ million)

FY4/20results

FY4/21
results

FY4/22plan

YoYchangeYoYchange(%)

Net sales

24,701

19,41925,000+5,581+28.7

Gross profit

9,753

7,216

9,200

+1,984

+27.5

9,596

9,358

9,900

+542

+5.8

157

(2,141)(700)+1,441-262(1,999)(670)+1,329

-

63

69

82

+13

+18.8

% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Segment income% of net sales

Number of stores

39.5
38.8
0.6
1.1

37.2
48.2

-

36.8
39.6

-

Figures in the table are rounded down
Segment loss is adjusted to ordinary income shown on the consolidated statements of income© 2020 AIN HOLDINGS INC. All Rights Reserved.

24

FY4/22 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2022 increase 6.0% and ordinary
income increase 22.5% YoY by opening new stores (80 dispensing pharmacies and 15 cosmetic
and drug stores).
YoY
FY4/20FY4/21
FY4/22
YoYchange(%)（¥ million）
results
resultsplanchangeNet sales

292,615

297,305

315,000 +17,695+6.0

Gross profit

46,861

46,15551,600+5,445+11.8

30,79335,22236,600+1,378+3.9

16,068

10,932

15,000+4,068+37.2

16,822

12,64915,500+2,851

+22.5

9,179

6,697

8,300

+1,603+23.9% of net sales

3.1

2.3

2.6

Earnings per
share(¥)

259.11189.04234.28+45.24

+23.9

55.00

55.00

55.00

+0.00

+0.0

% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Ordinary income% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

16.0
10.5
5.5
5.7

15.5
11.8
3.7
4.3

16.4
11.6
4.8
4.9

Figures in the table are rounded down
© 2020 AIN HOLDINGS INC. All Rights Reserved.

25

Inquiries related to this presentation should be addressed to

AIN HOLDINGS INC.
Corporate Planning Division
TEL(81)11-814-0010
FAX(81)11-814-5550
https://www.ainj.co.jp/
This document may not be reproduced or distributed to any third party without
prior approval of AIN HOLDINGS INC. This document has been prepared for
information purpose only and does not form part of a solicitation to sell orpurchase any securities. Information contained herein may be changed orrevised without prior notice. This document may contain forecastingstatements as to future results of operations. No forecast statement can be
guaranteed and actual results of operations may differ from those projected.

© 2020 AIN HOLDINGS INC. All Rights Reserved.

26